Trials / Unknown
UnknownNCT01313533
Biologically Modified Saphenous Vein Transplants for Improved CABG Outcomes
- Status
- Unknown
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 540 (estimated)
- Sponsor
- St. Luke's Hospital, Chesterfield, Missouri · Academic / Other
- Sex
- All
- Age
- 25 Years – 95 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to study the effects of polyarginine treated vein grafts on graft patency for patients undergoing coronary artery bypass surgery.
Detailed description
Double blind study with Lactated Ringers Solution and Lactated Ringers Solution with Arginine soaked for 10 minutes prior to grafting on the coronary arteries.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Polyarginine | Vein soak treated with polyarginine |
| DRUG | Vein soak treated with Lactated Ringers Solution | Vein soak |
Timeline
- Start date
- 2015-03-01
- Primary completion
- 2019-12-01
- Completion
- 2021-11-01
- First posted
- 2011-03-11
- Last updated
- 2019-04-04
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01313533. Inclusion in this directory is not an endorsement.